Evonik Industries AG
Evonik Industries AG (EVKIF) Financial Performance & Income Statement Overview
Review Evonik Industries AG (EVKIF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Evonik Industries AG (EVKIF) Income Statement & Financial Overview
Explore comprehensive income reports for Evonik Industries AG EVKIF, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $3.78B | $3.60B | $3.83B | $3.93B |
| Cost of Revenue | $2.77B | $2.94B | $2.80B | $2.88B |
| Gross Profit | $1.008B | $664.00M | $1.03B | $1.04B |
| Gross Profit Ratio | $0.27 | $0.18 | $0.27 | $0.27 |
| R&D Expenses | $106.00M | $133.00M | $106.00M | $109.00M |
| SG&A Expenses | $580.00M | $649.00M | $596.00M | $826.00M |
| Operating Expenses | $711.00M | $681.00M | $702.00M | $699.00M |
| Total Costs & Expenses | $3.48B | $3.62B | $3.51B | $3.58B |
| Interest Income | $24.00M | $35.00M | $8.00M | $14.00M |
| Interest Expense | $51.00M | $54.00M | $53.00M | $56.00M |
| Depreciation & Amortization | $240.00M | $368.00M | $234.00M | $250.00M |
| EBITDA | $561.00M | $301.00M | $561.00M | $338.00M |
| EBITDA Ratio | $0.15 | $0.08 | $0.15 | $0.09 |
| Operating Income | $297.00M | -$17.00M | $326.00M | $346.00M |
| Operating Income Ratio | $0.08 | -$0.005 | $0.09 | $0.09 |
| Other Income/Expenses (Net) | -$27.00M | -$104.00M | -$52.00M | -$26.00M |
| Income Before Tax | $270.00M | -$121.00M | $274.00M | $57.00M |
| Income Before Tax Ratio | $0.07 | -$0.03 | $0.07 | $0.01 |
| Income Tax Expense | $34.00M | $28.00M | $47.00M | $61.00M |
| Net Income | $233.00M | -$152.00M | $223.00M | -$5.00M |
| Net Income Ratio | $0.06 | -$0.04 | $0.06 | -$0.001 |
| EPS | $0.50 | -$0.33 | $0.48 | -$0.01 |
| Diluted EPS | $0.50 | -$0.33 | $0.48 | -$0.01 |
| Weighted Avg Shares Outstanding | $466.00M | $466.00M | $464.58M | $466.00M |
| Weighted Avg Shares Outstanding (Diluted) | $466.00M | $466.00M | $464.58M | $466.00M |
The company's financials show resilient growth, with revenue advancing from $3.93B in Q2 2024 to $3.78B in Q1 2025. Gross profit remained healthy with margins at 27% in Q1 2025 compared to 27% in Q2 2024. Operating income hit $297.00M last quarter, sustaining a consistent 8% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $561.00M. Net income rose to $233.00M, while earnings per share reached $0.50. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan